Through the use of Physician-Directed Physiologic Insulin Resensitization (PIR), the physician can administer insulin more precisely, as a hormone rather than a drug. Using insulin in a manner that bio-mimics normal physiology, PIR is designed to help physicians to reduce their patients’ insulin resistance, which may help blood sugar more readily enter each cell and be converted into energy.
PIR is designed to help physicians to repair and regenerate their patients’ cells, peripherally at first, and then through repeated treatment sessions under a physician-directed care plan.
The physician-directed Care Plan is highly individualized and is prescribed to enable the patient to increase the time between treatments and decrease the length of each treatment as the patient’s condition improves.
Unfortunately, metabolic impairment is a chronic disease. If patients do not continue treatment, any improvements experienced may diminish over time.